Gastric Outlet Obstruction Clinical Trials

7 recruitingLast updated: May 13, 2026

There are 7 actively recruiting gastric outlet obstruction clinical trials across 8 countries. Studies span Not Applicable. Top locations include Milan, Italy, Düsseldorf, Germany, Ghent, Belgium. Updated daily from ClinicalTrials.gov.


Gastric Outlet Obstruction Trials at a Glance

7 actively recruiting trials for gastric outlet obstruction are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Milan, Düsseldorf, and Ghent. Lead sponsors running gastric outlet obstruction studies include Corewell Health West, Evangelisches Krankenhaus Düsseldorf, and AdventHealth.

Browse gastric outlet obstruction trials by phase

Treatments under study

About Gastric Outlet Obstruction Clinical Trials

Looking for clinical trials for Gastric Outlet Obstruction? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastric Outlet Obstruction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastric Outlet Obstruction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Comparing Endoscopic Ultrasound vs Surgical Gastrojejunostomy for Management of GOO.

Malignant Gastric Outlet Obstruction
AdventHealth70 enrolled1 locationNCT06128018
Recruiting

Prospective Registry Of Therapeutic EndoscopiC ulTrasound

Chronic PancreatitisGastric Outlet ObstructionAcute Pancreatic Fluid Collection+3 more
Paolo Giorgio Arcidiacono, MD510 enrolled1 locationNCT04813055
Recruiting

Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy

Pancreatic CancerGastric Outlet Obstruction
IRCCS San Raffaele250 enrolled5 locationsNCT06071507
Recruiting
Not Applicable

GT Metabolic Magnet System in Adults With Gastrointestinal Disorders

small bowel obstructionGastric Outlet ObstructionSuperior Mesenteric Artery Syndrome
GT Metabolic Solutions, Inc.35 enrolled1 locationNCT07317076
Recruiting
Not Applicable

Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass

Gastric Outlet ObstructionHypoglycemiaSteatohepatitis+2 more
University Hospital, Ghent20 enrolled2 locationsNCT05640947
Recruiting
Not Applicable

EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Conditions and Inaccessible Papilla/Biliodigestive Anastomosis (BDA)

Malignant Gastric Outlet ObstructionBiliary InterventionAltered Anatomy+2 more
Evangelisches Krankenhaus Düsseldorf40 enrolled1 locationNCT07096895
Recruiting
Not Applicable

Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction

Malignant Gastric Outlet Obstruction
Corewell Health West16 enrolled1 locationNCT05986890